Understanding our terminology
Comirnaty JN.1 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine (nucleoside modified) bretovameran must be prepared carefully following the manufacturer’s instructions. We refer to it as Comirnaty 30 (JN.1) in our web articles.
Example procedure
We have produced an example template Standard Operating Procedure (SOP) for the preparation of the Comirnaty 30 (JN.1) vaccine. The attachment is presented in Word to enable adaptation locally, or as reference source to check that existing local procedures are robust and comprehensive. Within the SOP, red text indicates where detail is to be added locally.
Attachments
Update history
- Published